508 related articles for article (PubMed ID: 9847269)
1. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
Johnson JL; Nyole S; Okwera A; Whalen CC; Nsubuga P; Pekovic V; Huebner R; Wallis RS; Mugyenyi PN; Mugerwa RD; Ellner JJ
Am J Respir Crit Care Med; 1998 Dec; 158(6):1790-6. PubMed ID: 9847269
[TBL] [Abstract][Full Text] [Related]
2. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1997 Sep; 46(RR-15):1-10. PubMed ID: 9332982
[TBL] [Abstract][Full Text] [Related]
3. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
[TBL] [Abstract][Full Text] [Related]
4. The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study.
Elliott AM; Hurst TJ; Balyeku MN; Quigley MA; Kaleebu P; French N; Biryahwaho B; Whitworth JA; Dockrell HM; Hayes RJ
Int J Tuberc Lung Dis; 1999 Mar; 3(3):239-47. PubMed ID: 10094326
[TBL] [Abstract][Full Text] [Related]
5. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.
Whalen CC; Johnson JL; Okwera A; Hom DL; Huebner R; Mugyenyi P; Mugerwa RD; Ellner JJ
N Engl J Med; 1997 Sep; 337(12):801-8. PubMed ID: 9295239
[TBL] [Abstract][Full Text] [Related]
6. Two-step tuberculin skin testing in HIV-infected persons in Uganda.
Hecker MT; Johnson JL; Whalen CC; Nyole S; Mugerwa RD; Ellner JJ
Am J Respir Crit Care Med; 1997 Jan; 155(1):81-6. PubMed ID: 9001293
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture.
Katial RK; Hershey J; Purohit-Seth T; Belisle JT; Brennan PJ; Spencer JS; Engler RJ
Clin Diagn Lab Immunol; 2001 Mar; 8(2):339-45. PubMed ID: 11238218
[TBL] [Abstract][Full Text] [Related]
8. Selection of skin test antigens to evaluate PPD anergy.
Wright PW; Crutcher JE; Holiday DB
J Fam Pract; 1995 Jul; 41(1):59-64. PubMed ID: 7798066
[TBL] [Abstract][Full Text] [Related]
9. Reliability of anergy skin testing in persons with HIV infection. The pulmonary Complications of HIV Infection Study Group.
Chin DP; Osmond D; Page-Shafer K; Glassroth J; Rosen MJ; Reichman LB; Kvale PA; Wallace JM; Poole WK; Hopewell PC
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1982-4. PubMed ID: 8665065
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia.
Delgado JC; Tsai EY; Thim S; Baena A; Boussiotis VA; Reynes JM; Sath S; Grosjean P; Yunis EJ; Goldfeld AE
Proc Natl Acad Sci U S A; 2002 May; 99(11):7576-81. PubMed ID: 12032325
[TBL] [Abstract][Full Text] [Related]
11. Presumptive TB prophylaxis rejected.
Torres G
GMHC Treat Issues; 1997 Oct; 11(10):5-6. PubMed ID: 11364822
[TBL] [Abstract][Full Text] [Related]
12. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
[TBL] [Abstract][Full Text] [Related]
13. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff.
Janis EM; Allen DW; Glesby MJ; Carey LA; Mundy LM; Gopalan R; Chaisson RE
Am J Med; 1996 Feb; 100(2):186-92. PubMed ID: 8629653
[TBL] [Abstract][Full Text] [Related]
14. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
[TBL] [Abstract][Full Text] [Related]
15. Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand.
Yanai H; Uthaivoravit W; Mastro TD; Limpakarnjanarat K; Sawanpanyalert P; Morrow RH; Nieburg P
Int J Tuberc Lung Dis; 1997 Oct; 1(5):427-34. PubMed ID: 9441097
[TBL] [Abstract][Full Text] [Related]
16. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
[TBL] [Abstract][Full Text] [Related]
17. Underestimation of Mycobacterium tuberculosis infection in HIV-infected subjects using reactivity to tuberculin and anergy panel.
García-García ML; Valdespino-Gómez JL; García-Sancho C; Mayar-Maya ME; Palacios-Martínez M; Balandrano-Campos S; Escobar-Gutiérrez A; Peruga A; Weissenbacher M; Daniels E
Int J Epidemiol; 2000 Apr; 29(2):369-75. PubMed ID: 10817138
[TBL] [Abstract][Full Text] [Related]
18. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.
Halsey NA; Coberly JS; Desormeaux J; Losikoff P; Atkinson J; Moulton LH; Contave M; Johnson M; Davis H; Geiter L; Johnson E; Huebner R; Boulos R; Chaisson RE
Lancet; 1998 Mar; 351(9105):786-92. PubMed ID: 9519950
[TBL] [Abstract][Full Text] [Related]
19. Questions about a placebo-controlled trial of preventive therapy for tuberculosis in HIV-infected Ugandans.
Desvarieux M
N Engl J Med; 1998 Mar; 338(12):841; author reply 842-3. PubMed ID: 9508639
[No Abstract] [Full Text] [Related]
20. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis.
MMWR Recomm Rep; 1991 Apr; 40(RR-5):27-32. PubMed ID: 2034206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
